Sign Up to like & get recommendations! 1
Published in 2019 at "Annals of Clinical and Translational Neurology"
DOI: 10.1002/acn3.692
Abstract: To determine a predictive factor for the risk of conversion from ocular myasthenia gravis (OMG) to generalized MG (GMG) in a prospective study. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Neurology and Therapy"
DOI: 10.1007/s40120-021-00292-x
Abstract: Many patients with ocular myasthenia gravis (OMG) progress to generalized disease within the first 2 years of the onset of ocular symptoms. Several retrospective studies have identified risk factors associated with generalization, however these studies… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the Neurological Sciences"
DOI: 10.1016/j.jns.2017.09.036
Abstract: Ocular myasthenia is the milder end of the myasthenia gravis spectrum but treatment can be challenging especially in older patients. We retrospectively studied all patients on our database with ocular myasthenia (OMG), positive for acetylcholine… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Pediatric neurology"
DOI: 10.1016/j.pediatrneurol.2018.06.007
Abstract: BACKGROUND Isolated ocular myasthenia gravis (MG) is sparingly common in children relative to adults, ranging from 71% to 93% of all children with MG. PURPOSE We aimed to characterize the ocular manifestations and outcomes in… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Pediatric neurology"
DOI: 10.1016/j.pediatrneurol.2021.01.009
Abstract: BACKGROUND In autoimmune myasthenia gravis (MG), autoantibodies target the neuromuscular junction. Ocular myasthenia gravis (OMG) is localized, affecting only extraocular and/or levator palpebrae muscles. OMG presents across all ages, varying in presentation, treatment modalities, and… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Orbit"
DOI: 10.1080/01676830.2022.2079677
Abstract: Dear Editor, we would like to share ideas on the publication “Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine [1].” Ocular myasthenia gravis was generated by the viral vector Oxford-AstraZeneca coronavirus… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical and Experimental Optometry"
DOI: 10.1080/08164622.2022.2029683
Abstract: ABSTRACT Myasthenia gravis is a rare autoimmune disease characterised by autoantibodies preventing normal function of acetylcholine receptors at the post-synaptic membrane of the neuromuscular junction. This causes weakness of skeletal muscles that can be variable… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Current Opinion in Ophthalmology"
DOI: 10.1097/icu.0000000000000526
Abstract: Purpose of review Myasthenia gravis is an autoimmune disease that commonly affects the palpebral and extraocular muscles. Ocular myasthenia gravis (OMG) is a variant of the disease that is confined to the ocular muscles but… read more here.
Sign Up to like & get recommendations! 1
Published in 2020 at "Optometry and Vision Science"
DOI: 10.1097/opx.0000000000001512
Abstract: SIGNIFICANCE This case emphasizes the high degree of suspicion necessary for a timely diagnosis of myasthenia gravis. PURPOSE This report discusses a case of ocular myasthenia gravis presenting as a pseudo-third nerve palsy with ptosis.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Journal of Neurology"
DOI: 10.1111/ene.14036
Abstract: This study was conducted to evaluate whether post‐thymectomy rapid remission of ocular myasthenia gravis (oMG) is a prognostic indicator of good long‐term neurological outcome. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "European Journal of Neurology"
DOI: 10.1111/ene.15292
Abstract: To analyze disease generalization in patients with ocular myasthenia gravis (OMG) treated with immunosuppression compared with patients without immunosuppression treatment. read more here.